Illumina adds ex-Medco exec to board of directors

Associated Press

SAN DIEGO (AP) — Genetic analysis instrument company Illumina Inc. said Thursday it elected Robert Epstein to its board of directors.

Epstein was the chief medical officer of Medco Health Solutions for 13 years, and after Medco acquired United BioSource Corp. in 2010, he became president and chief research officer of Medco-UBC. United BioSource helps companies design studies of drugs and medical devices, collect information and perform research on drugs and medical devices.

Medco, a pharmacy benefits manager, was acquired by former competitor Express Scripts Holding Co. earlier this year.

Epstein will be the 10th member of Illumina's board.